Are insiders buying ACRV stock?

Yes — 4 distinct insiders have bought ACRV (Acrivon Therapeutics, Inc.) on the open market, including 1 cluster buy where two or more insiders bought within a rolling window. The most recent qualifying activity was Jan 16, 2026.

How much ACRV stock have insiders bought?

Insiders have bought a combined $20.1M of ACRV across 4 open-market purchases, based on SEC Form 4 filings.

What is an insider cluster buy in ACRV?

A cluster buy is two or more distinct Acrivon Therapeutics, Inc. insiders — officers, directors, or 10% owners — each buying ACRV on the open market within a rolling window. ACRV has 1 detected cluster buy to date.

Where does this ACRV insider trading data come from?

Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.

ACRV insider buying

1 cluster buy

Acrivon Therapeutics, Inc. · Healthcare

When two or more insiders at Acrivon Therapeutics, Inc. buy ACRV on the open market around the same time, that clustered conviction is one of the highest-signal patterns in SEC filing data. Below is every cluster we've detected in ACRV plus the full record of qualifying open-market buys, each parsed directly from Form 4 filings and linked back to the source on SEC EDGAR.

Clusters

Distinct insiders

Total bought

$20.1M

Market cap

$76.2M

Detected clusters

Jan 13 – Jan 14, 2026
Detected Jan 14, 2026
High conviction3 insiders
Total bought
$114.5K
Market cap
$76.2M

All notable open-market buys in ACRV

Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.

Date	Insider	Shares	Price	Value	Filing
Jan 14, 2026	Blume-Jensen Petercluster Director, President and CEO	49,000	$1.68	$82.3K	SEC ↗
Jan 14, 2026	Levy Adam D.cluster Chief Financial Officer	8,832	$1.70	$15.0K	SEC ↗
Jan 13, 2026	Devroe Ericcluster Chief Operating Officer	10,000	$1.72	$17.2K	SEC ↗
Apr 11, 2024	PERCEPTIVE LIFE SCIENCES MASTER FUND LTD 10% Owner	2,353,000	$8.50	$20.0M	SEC ↗

More Healthcare stocks with insider cluster buys

All insider buying in Healthcare →

ACRV insider buying — FAQ

Are insiders buying ACRV stock?: Yes — 4 distinct insiders have bought ACRV (Acrivon Therapeutics, Inc.) on the open market, including 1 cluster buy where two or more insiders bought within a rolling window. The most recent qualifying activity was Jan 16, 2026.
How much ACRV stock have insiders bought?: Insiders have bought a combined $20.1M of ACRV across 4 open-market purchases, based on SEC Form 4 filings.
What is an insider cluster buy in ACRV?: A cluster buy is two or more distinct Acrivon Therapeutics, Inc. insiders — officers, directors, or 10% owners — each buying ACRV on the open market within a rolling window. ACRV has 1 detected cluster buy to date.
Where does this ACRV insider trading data come from?: Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.

How we track insider buying in ACRV

We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy ACRV within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Every figure on this page traces back to an official filing; open any row to jump straight to the source document. What counts as a cluster buy?

This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding ACRV.